Ajanta Pharma Promoter Pledges Additional Shares for NCD Issuance
Ajanta Pharma Ltd 路 Encumbered Shares - Invocation / Release 路 06 Oct 2026, 4:02 pm
Ajanta Pharma Promoter Pledges Additional Shares for NCD Issuance Ajanta Pharma promoter entity, Aayush Agrawal (Trustee of Aayush Agrawal Trust), created a pledge on 4,60,000 equity shares (0.37% of total share capital) on 28th Sep'26 in favor of CTL Trusteeship Ltd to back an NCD issuance. Following this transaction, the trust's total encumbered holding increased from 1,16,42,386 shares (9.32% of total share capital) to 1,21,02,386 shares (9.69% of total share capital), against its overall holding of 1,41,12,924 equity shares (11.29% stake).
Original exchange filing (PDF)
More announcements from Ajanta Pharma Ltd
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 18, 2026 for Aayush Agrawal, .... 路 18 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 16, 2026 for Aayush Agrawal, .... 路 17 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Aayush Agrawal, .... 路 09 Nov 2026
- Pls find enclosed Earnings Call Written Transcript 路 04 Nov 2026
- Pls find enclosed Audio recording of Earnings Call 路 30 Oct 2026
- Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 30 Oct 2026
- Pls find enclosed results for the quarter ended 30.09.2026. 路 30 Oct 2026
- Pls find enclosed Financial Results for the quarter ended 30.09.2026. 路 30 Oct 2026
